Skip to content Search the desk⌘ Ctrl K Agent Sign in D Dogwood Therapeutics, Inc.
D DWTX Dogwood Therapeutics, Inc.
D DWTX Dogwood Therapeutics, Inc.
Earnings When Dogwood Therapeutics, Inc. reports, what it reported each quarter, and how the stock took the results.
20 quarters. Mar 31, 2020 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
Mar 17, before the open
Wed, Mar 17, 2027 in 118 days
Projected from its last 8 releases. The company has not named the day yet.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Mar 11 – 26 Quarter by quarter 3 years 5 years
Revenue Net income EPS Gross profit Operating income Operating cash flow
Q3 2026 $ 1 0 0 . 0 0 K $100.00K No Q3 2025 on file
Revenue $100.00K —
Net income -$4.88M N/M
EPS -$0.14 N/M Q2 2026 Aug 13, 2026, before the openDogwood Therapeutics, Inc. · CIK 1818844 · Engraved from SEC EDGAR
Revenue — —
Net income -$11.53M N/M
EPS -$0.34 N/M
Revenue — —
Net income -$4.99M N/M
EPS -$0.15 N/M
Revenue — —
Net income -$3.78M N/M
EPS — —
Results day Typical move ±4.8% A typical move of 4.8% either way
Up after 3 of 9, down after 6.
−3.7% −12.9% −2.6%
When it reports
Usual day Thursday 5 of its last 8
After quarter end 37 to 77 days
10-Q filed 38 to 45 days over its last 8
10-K filed 73 to 82 days over its last 6 ended Sep 30, 2024 · filed Nov 8, 2024 · 39 d ended Dec 31, 2024 · filed Mar 31, 2025 · 90 d ended Mar 31, 2025 · filed May 9, 2025 · 39 d ended Jun 30, 2025 · filed Aug 13, 2025 · 44 d ended Sep 30, 2025 · filed Nov 7, 2025 · 38 d Q2 2026 Jun 30, 2026 Aug 13, 2026 · pre-market Aug 14, 2026 45 d 10-Q — — -$0.34 +2.0%
Q1 2026 Mar 31, 2026 May 14, 2026 · pre-market May 15, 2026 45 d 10-Q — — -$0.15 +5.9%
FY 2025 Q4 2025 derived Dec 31, 2025 Mar 18, 2026 · pre-market Mar 18, 2026 77 d 10-K — — — 6.8% Q3 2025 Sep 30, 2025 Nov 6, 2025 · pre-market Nov 7, 2025 38 d 10-Q — — -$8.20 5.1% Q2 2025 Jun 30, 2025 Aug 13, 2025 · pre-market Aug 13, 2025 44 d 10-Q — — -$1.99 +0.8% Q1 2025 Mar 31, 2025 May 8, 2025 · pre-market May 9, 2025 39 d 10-Q — — -$8.45 2.6%
FY 2024 Q4 2024 derived Dec 31, 2024 Mar 31, 2025 · market hours Mar 31, 2025 90 d 10-K — — — 12.9% Q3 2024 Sep 30, 2024 Nov 7, 2024 · pre-market Nov 8, 2024 39 d 10-Q — — -$2.05 3.7% Q2 2024 Jun 30, 2024 Aug 8, 2024 · market hours Aug 9, 2024 40 d 10-Q — — -$1.15 — Q1 2024 Mar 31, 2024 May 9, 2024 · pre-market May 10, 2024 40 d 10-Q — — -$1.68 —
FY 2023 Q4 2023 derived Dec 31, 2023 Feb 29, 2024 · pre-market Mar 1, 2024 61 d 10-K — — — — Q3 2023 Sep 30, 2023 Nov 13, 2023 · pre-market Nov 13, 2023 44 d 10-Q — — -$1.62 —
FY 2022 Q4 2022 Mar 31, 2023 May 11, 2023 · pre-market — — — — — -$0.08 — Q1 2022 Jun 30, 2022 Aug 11, 2022 · pre-market Aug 12, 2022 43 d 10-Q — — -$0.44 —
FY 2021 Q4 2021 Mar 31, 2022 May 12, 2022 · pre-market — — — — — -$0.48 —
FY 2020 Q4 2020 derived Dec 31, 2020 Mar 18, 2021 · pre-market Mar 23, 2021 82 d 10-K — — — — Q3 2020 Sep 30, 2020 — — — — — — -$0.56 — Q2 2020 Jun 30, 2020 — — — — — — -$0.14 — Q1 2020 Mar 31, 2020 — — — — — — -$0.10 —
Earlier years, FY 2020 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
May 15, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Net income -$3.78M Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m n/m n/m n/m n/m
EPS — EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m n/m n/m n/m n/m 4.8% by the close of Nov 5
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
+2.0% by the close of Aug 13
ended Dec 31, 2025 · filed Mar 18, 2026 · 77 d ended Mar 31, 2026 · filed May 15, 2026 · 45 d ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d ended Sep 30, 2026 · filed Nov 6, 2026 · 37 d window Mar 11 – 26 · projected The stock’s move from the last close before each release to the first close after it, over the last 9 releases. Largest: −12.9% after Q4 2024.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks